Cargando…

Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease

BACKGROUND: This study aimed to assess whether the plasminogen activator inhibitor‐1/tissue plasminogen activator (PAI‐1/tPA) ratio as a prothrombotic state is useful for optimizing cardiac treatment strategy. METHODS AND RESULTS: Using BARI 2D (Bypass Angioplasty Revascularization Investigation 2 D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsujimoto, Tetsuro, Kajio, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497335/ https://www.ncbi.nlm.nih.gov/pubmed/30646801 http://dx.doi.org/10.1161/JAHA.118.011207

Ejemplares similares

Optimal cardiac strategy based on the history of myocardial infarction in type 2 diabetic patients with coronary artery disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Effects of β‐blockers on all‐cause mortality in patients with type 2 diabetes and coronary heart disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Thiazide Use and Cardiovascular Events in Type 2 Diabetic Patients With Well-Controlled Blood Pressure
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes using non‐steroidal anti‐inflammatory drugs
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Seasonal Variations of Severe Hypoglycemia in Patients With Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, and Non-diabetes Mellitus: Clinical Analysis of 578 Hypoglycemia Cases
por: Tsujimoto, Tetsuro, et al.
Publicado: (2014)

Intensive Blood Pressure Treatment for Resistant Hypertension: Secondary Analysis of a Randomized Controlled Trial
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Thiazide Use and Decreased Risk of Heart Failure in Nondiabetic Patients Receiving Intensive Blood Pressure Treatment
por: Tsujimoto, Tetsuro, et al.
Publicado: (2020)

Favourable changes in mortality in people with diabetes: US NHANES 1999–2010
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Obesity, diabetes, and length of time in the United States: Analysis of National Health and Nutrition Examination Survey 1999 to 2012
por: Tsujimoto, Tetsuro, et al.
Publicado: (2016)

Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
por: Tsujimoto, Tetsuro, et al.
Publicado: (2018)

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
por: Tsujimoto, Tetsuro, et al.
Publicado: (2020)

High risk of renal dysfunction in patients with fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2017)

Short‐term changes in pancreatic α‐cell function after the onset of fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

Left Hemiplegia Possibly Due to Glucose Reperfusion Injury after Recovery of Severe Hypoglycemia in a Woman with Type 2 Diabetes Mellitus
por: Sugito, Erika, et al.
Publicado: (2021)

Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes
por: Nakamura, Tomoka, et al.
Publicado: (2023)

Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population‐based observational study
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

COVID-19 and thrombotic complications—the role of anticoagulants, antiplatelets and thrombolytics
por: Khandelwal, Gaurav, et al.
Publicado: (2021)

Improvement of glycemic control without severe hypoglycemia in a type 1 diabetes patient undergoing hemodialysis after a change from insulin glargine to insulin degludec
por: Takahashi, Nobuyuki, et al.
Publicado: (2016)

Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study
por: Tsujimoto, Tetsuro, et al.
Publicado: (2011)

Beneficial effects through aggressive coronary screening for type 2 diabetes patients with advanced vascular complications
por: Tsujimoto, Tetsuro, et al.
Publicado: (2016)

COVID CORONARY: INTRACORONARY THROMBOLYTICS TO THE RESCUE
por: Randall, Morgan, et al.
Publicado: (2022)

Comparison of Shear Stress–Induced Thrombotic and Thrombolytic Effects Among 3 Different Antithrombotic Regimens in Patients With Acute Coronary Syndrome
por: Kim, Minsuk, et al.
Publicado: (2020)

Poorly controlled type 2 diabetes with no progression of diabetes-related complications and low levels of advanced glycation end products: A Case report
por: Nakamura, Tomoka, et al.
Publicado: (2019)

Use of Intra-arterial Thrombolytic Therapy for Acute Treatment of Frostbite in 62 Patients with Review of Thrombolytic Therapy in Frostbite
por: Gonzaga, Teresa, et al.
Publicado: (2016)

Efficacy of thrombolytics in patients with acute coronary syndrome
por: Vasin, A, et al.
Publicado: (2021)

Prediction of 90-day mortality in patients without diabetes by severe hypoglycemia: blood glucose level as a novel marker of severity of underlying disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2014)

Heparin Alters Viral Serpin, Serp-1, Anti-Thrombolytic Activity to Anti-Thrombotic Activity
por: Li, Xing, et al.
Publicado: (2008)

Significantly increased risk of cancer in diabetes mellitus patients: A meta‐analysis of epidemiological evidence in Asians and non‐Asians
por: Noto, Hiroshi, et al.
Publicado: (2011)

Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes
por: Imai, Kenjiro, et al.
Publicado: (2014)

Associations of Observational and Genetically Determined Caffeine Intake With Coronary Artery Disease and Diabetes Mellitus
por: Said, M. Abdullah, et al.
Publicado: (2020)

Effectiveness of Prior Use of Beta-Blockers for Preventing Adverse Influences of Severe Hypoglycemia in Patients With Diabetes: An Observational Study
por: Tsujimoto, Tetsuro, et al.
Publicado: (2015)

Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study
por: Fawzy, Manal S., et al.
Publicado: (2017)

Editorial on management of diabetes mellitus with coronary artery disease
por: Aronow, Wilbert S.
Publicado: (2011)

Effects of Cardiac Rehabilitation on Cardiac Function and Quality of Life in Patients with Ischemic Nonobstructive Coronary Artery Disease and Diabetes Mellitus
por: Wen, Yuan, et al.
Publicado: (2022)

Thrombolytic therapy for myocardial infarction facilitated by mobile coronary care.
por: Wilson, C., et al.
Publicado: (2004)

New Thrombolytic Infusion Application of Dissolving Renal Artery Embolic Thrombosis: Low-Dose Slow-Infusion Thrombolytic Therapy
por: Karakurt, Ahmet
Publicado: (2018)

Distribution of coronary artery disease in acute coronary syndrome patients with diabetes mellitus
por: Gulin, D, et al.
Publicado: (2013)

Intravenous Thrombolytic Treatment in the Oldest Old
por: García-Caldentey, Juan, et al.
Publicado: (2012)

The Severity of Coronary Arterial Stenosis in Patients With Acute ST-Elevated Myocardial Infarction: A Thrombolytic Therapy Study
por: Kilic, Salih, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ogquq8t3op0t2a49prbq3lectt